Effect of montelukast on symptoms and exhaled nitric oxide levels in 7- to 14-year-old children with seasonal allergic rhinitis

Razi C., Bakirtas A., HARMANCI K., Turktas P., Erbas D.

ANNALS OF ALLERGY ASTHMA & IMMUNOLOGY, vol.97, no.6, pp.767-774, 2006 (SCI-Expanded) identifier identifier


Background: Cysteinyl leukotrienes have been found to exert potent inflammatory effects in the upper airways and play a fundamental role in the pathogenesis of allergic rhinitis. Previous studies have reported increased levels of exhaled nitric oxide (eNO) in patients with allergic rhinitis without asthma symptoms.